Search
中/EN
Contact/Message
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
Search
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
中/EN
Contact/Message
Innovate
Your current position:
Home
Innovate
International innovative drugs
Sotyktu
Sotyktu
departments:
皮肤科
drug:
片剂
Active:
Deucravacitinib
indication:
银屑病
Licensor:
Bristol-Myers Squibb Pharma EEIG
Approved Country/Region:
EMA
Approval time:
2023-03-24